Real-time enrollment status for this atrial fibrillation clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT05712200 |
| Recruiting Status | Recruiting |
| Condition | Atrial Fibrillation |
| Phase | PHASE3 |
| Target Enrollment | 2,500 participants |
| Active Locations | 174 sites in the US |
| Sponsor | Anthos Therapeutics, Inc. |
| Last Updated on CT.gov | July 13, 2026 (Jul 13, 2026) |
As of October 16, 2026: Clinical trial NCT05712200 is currently recruiting participants. This phase3 study for atrial fibrillation is actively seeking new participants at 174 locations across the United States. The study is sponsored by Anthos Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05712200 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 174 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05712200 was last updated Jul 13, 2026 (July 13, 2026). HelloStudys verifies this status automatically.